JTE-162
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JTE-162, covering 2026-02-09 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS) [Phase 1]